A Special Protocol Assessment Agreement Reached with the U.S. Food and Drug Administration for Phase 3 clinical trial of Sovateltide for the treatment of acute cerebral ischemic stroke patients Special Protocol Assessment Agreement Reached Between Pharmazz, Inc. and the U.S. Food and Drug Administration for Phase 3 Clinical Trial of Sovateltide

"Advancements in Acute Ischemic Stroke Therapeutics Market CAGR of 4.6 %: A Ray of Hope for Stroke Patients", Says Market.us New York, Sept. 25, 2023 (GLOBE NEWSWIRE) -- According to a recent report by Market.us, the Global Acute Ischemic Stroke Therapeutics Market size is expected to be worth around USD 14.0 Billion by...

Vena Medical Celebrates First Procedures with Category-Defining Balloon Distal Access Catheter™ (BDAC) Kitchener, Ontario, Aug. 16, 2022 (GLOBE NEWSWIRE) -- Vena Medical, a leading developer of cutting-edge neurovascular devices, announces the successful treatment of the first five patients in the...

Vena Medical Celebrates First Procedures with Category-Defining Balloon Distal Access Catheter™ (BDAC) Kitchener, Ontario, Aug. 16, 2022 (GLOBE NEWSWIRE) -- Vena Medical, a leading developer of cutting-edge neurovascular devices, announces the successful treatment of the first five patients in the...

Hospital Uses 'Lean' Manufacturing Techniques to Speed Stroke Care Study Highlights: A hospital stroke team used auto industry "lean" manufacturing principles to accelerate stroke treatment times. The average time between patients arriving and receiving...